======= TAF6L ======= == Gene Information == * **Official Symbol**: TAF6L * **Official Name**: TATA-box binding protein associated factor 6 like * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10629|10629]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y6J9|Q9Y6J9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TAF6L&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TAF6L|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602946|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Functions as a component of the PCAF complex. The PCAF complex is capable of efficiently acetylating histones in a nucleosomal context. The PCAF complex could be considered as the human version of the yeast SAGA complex. |TAF| |DUF1546| |SLIK (SAGA-like) complex| |STAGA complex| |RNA polymerase II preinitiation complex assembly| |SAGA complex| |transcription preinitiation complex assembly| |histone deacetylase complex| |transcription factor TFIID complex| |histone H3 acetylation| |histone acetyltransferase activity| |histone acetylation| |internal peptidyl-lysine acetylation| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |protein acetylation| |chromatin remodeling| |transcription initiation from RNA polymerase II promoter| |protein acylation| |protein-DNA complex assembly| |DNA-templated transcription, initiation| |protein-DNA complex subunit organization| |transcription coactivator activity| |peptidyl-lysine modification| |histone modification| |covalent chromatin modification| |transcription by RNA polymerase II| |protein heterodimerization activity| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |chromatin organization| |cellular protein-containing complex assembly| |peptidyl-amino acid modification| |chromosome organization| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |DNA binding| |protein-containing complex assembly| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |protein-containing complex subunit organization| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp307|Rapamycin 2μM plus Cyclosporin-A 3μM R07 exp307]]|-2.17| |[[:results:exp140|Nicotinate 1000μM R03 exp140]]|-2.01| |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|-1.81| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|-1.7| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|1.71| |[[:results:exp34|Rotenone 20μM R00 exp34]]|1.75| |[[:results:exp59|UMK57 1μM R01 exp59]]|1.76| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|1.81| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|1.99| |[[:results:exp517|Quercetin 20μM R08 exp517]]|2.12| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|2.5| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|3.04| ^Gene^Correlation^ |[[:human genes:s:supt7l|SUPT7L]]|0.673| |[[:human genes:t:tada2b|TADA2B]]|0.667| |[[:human genes:t:tada1|TADA1]]|0.631| |[[:human genes:t:taf5l|TAF5L]]|0.626| |[[:human genes:m:med13|MED13]]|0.621| |[[:human genes:c:ccdc101|CCDC101]]|0.604| |[[:human genes:t:tada3|TADA3]]|0.592| |[[:human genes:s:supt20h|SUPT20H]]|0.568| |[[:human genes:m:med23|MED23]]|0.552| |[[:human genes:m:mllt1|MLLT1]]|0.531| |[[:human genes:m:med13l|MED13L]]|0.516| |[[:human genes:t:tle4|TLE4]]|0.51| |[[:human genes:a:atxn7|ATXN7]]|0.501| |[[:human genes:h:hdac8|HDAC8]]|0.5| |[[:human genes:b:brpf1|BRPF1]]|0.48| |[[:human genes:u:usp22|USP22]]|0.468| |[[:human genes:p:prr12|PRR12]]|0.465| |[[:human genes:k:kat2a|KAT2A]]|0.452| |[[:human genes:e:ehmt2|EHMT2]]|0.44| |[[:human genes:m:med16|MED16]]|0.43| |[[:human genes:f:fli1|FLI1]]|0.43| |[[:human genes:u:ube3a|UBE3A]]|0.424| |[[:human genes:t:tti2|TTI2]]|0.42| |[[:human genes:a:atf7ip|ATF7IP]]|0.417| |[[:human genes:m:med7|MED7]]|0.409| |[[:human genes:w:wdr24|WDR24]]|0.404| |[[:human genes:m:med25|MED25]]|0.402| Global Fraction of Cell Lines Where Essential: 14/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|2/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|1/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|2/75| |lymphocyte|0/14| |ovary|1/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|2/15| |prostate|1/1| |skin|1/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|2/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 511 * **Expression level (log2 read counts)**: 4.71 {{:chemogenomics:nalm6 dist.png?nolink |}}